Immune Checkpoint Inhibitors — The Need for Innovation
P. Connor Johnson, Justin F. Gainor, Ryan J. Sullivan, Dan L. Longo, Bruce A. Chabner
Abstract
Immune checkpoint inhibitors represent a major advance in the treatment of cancer. The authors argue that future efforts should focus less on redundant agents and more on new approaches to immunotherapy.
Topics & Concepts
ImmunotherapyCancer immunotherapyImmune systemImmune checkpointFocus (optics)Computer scienceMedicineImmunologyOpticsPhysicsCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmune Cell Function and Interaction